Amathus Therapeutics
Amathus Therapeutics is a biotechnology firm that works on compounds to treat stress and Parkinson's disease. Their molecular processes include oxidative stress response, proteasomal degradation, unfolded protein response, autophagy, and mitophagy.
Industries
biotechnology
health-care
product-research
Nr. of Employees
small (1-50)
Products
Small Molecule Therapeutics for Parkinson's Disease
Develops small molecule drugs aimed at treating Parkinson's disease by targeting underlying biological pathways.
Small Molecule Therapeutics for Stress-Related Disorders
Creates small molecule drugs targeting biological pathways to treat stress and related disorders.
Small Molecule Therapeutics for Parkinson's Disease
Develops small molecule drugs aimed at treating Parkinson's disease by targeting underlying biological pathways.
Small Molecule Therapeutics for Stress-Related Disorders
Creates small molecule drugs targeting biological pathways to treat stress and related disorders.